Indefinite Delivery Contract SPE2DP26D0004
- Not listed
- The U.S. Department of Defense Medical Supply Chain awarded an Indefinite Delivery Contract to Sanofi Vaccines US Inc. (a division of Sanofi Pasteur Inc.) on December 12, 2025, with a ceiling value of $728,284.53 and an ultimate completion date of December 11, 2026. This single-award IDV carries no set-aside designation and serves as the parent contract vehicle for vaccine procurement to support Department of Defense immunization requirements and pandemic preparedness objectives. The prime...
- The Defense Logistics Agency Troop Support Medical awarded Sanofi Pasteur Inc. an indefinite delivery contract with a potential value of $8,519,232.30 to supply influenza virus vaccinations. Under this contract, three firm fixed price delivery orders have been issued to date for a total of $5,729,208.20. The delivery orders require Sanofi Pasteur to provide vaccinations from its Swiftwater, Pennsylvania facility to the agency between March 2023 and October 2023. The originating...
- Sanofi Pasteur Inc., a foreign-owned pharmaceutical manufacturer headquartered in Swiftwater, Pennsylvania, was awarded a single-award Indefinite Delivery Contract by the Defense Logistics Agency's Medical Supply Chain (a component of the Department of Defense) with a ceiling value of approximately $25.1 million and an ultimate completion date of February 13, 2026. The contract, awarded on February 14, 2025, is for the supply of influenza virus vaccines to support federal immunization...
- Sanofi Pasteur Inc., a foreign-owned pharmaceutical manufacturer headquartered in Swiftwater, Pennsylvania, was awarded a single-award Indefinite Delivery Contract by the U.S. Department of Defense Medical Supply Chain with a ceiling value of $839,467.53 and an ultimate completion date of November 26, 2025. The contract vehicle procures influenza virus vaccines for the Department of Defense and related federal agencies. No set-aside designation was applied to this indefinite delivery contract....
- The Defense Logistics Agency Troop Support Medical awarded a single-award indefinite delivery contract to Sanofi Pasteur Inc. to supply influenza virus vaccinations. Three firm fixed price delivery orders totaling approximately $4.6 million were placed against this vehicle to procure vaccines for 2022-2023 flu seasons. Deliveries will be made from Sanofi Pasteur's Swiftwater, Pennsylvania facility by specified dates ranging from March 2022 to September 2022. No set-aside provisions were applied....
- This Indefinite Delivery Contract, awarded on March 15, 2025, by the Department of Veterans Affairs National Acquisition Center to Sanofi Vaccines US Inc. (formerly Sanofi Pasteur Inc.), provides influenza virus vaccine for the 2025-2026 flu season with a contract ceiling value of $113,670.50 and a performance period extending through March 14, 2026. The contract represents a single-award, non-set-aside procurement intended to supply influenza vaccines to multiple federal healthcare systems,...
- The Defense Logistics Agency Troop Support Medical awarded a single-award, firm fixed price Indefinite Delivery Contract to Sanofi Pasteur Inc. to support influenza immunization programs. Under the contract, Sanofi Pasteur will deliver approximately $1.35 million in influenza virus vaccines from its Swiftwater, Pennsylvania facility. A $1.25 million firm fixed price delivery order was issued against this contract for influenza virus vaccine to be supplied through May 2021. The originating...
- The Defense Logistics Agency Troop Support Medical awarded Sanofi Pasteur Inc. a single award, indefinite delivery contract with a potential value of $567,566.40 to provide 850,886,1267 units of influenza virus vaccine. A firm fixed price delivery order against this contract specifies performance at Sanofi Pasteur Inc.'s Swiftwater, Pennsylvania facility from February 9, 2022 through May 13, 2022. The originating pre-solicitation sought sources capable of providing 60,000 doses of Southern...
- The Defense Logistics Agency Troop Support awarded a single-award indefinite delivery contract to Sanofi Pasteur Inc. for the supply of Southern Hemisphere influenza vaccine. The potential value of the contract is $397,455. No set-aside was used. The contract aims to procure approximately 29,000 doses of a pre-measured 0.5 mL influenza vaccine for intramuscular administration to individuals aged 6 months and older. The vaccine must be FDA-approved and ACIP recommended, using the formula...
- This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. The 5-year contract, valued at up to $4,023,280.80, is for the provision of Influenza Virus Vaccines in support of public health preparedness missions. Sanofi Pasteur holds multiple IDVs with various federal agencies, including the Department of Health and Human Services, Centers for Disease Control and Prevention, and...
Sanofi Vaccines US Inc., a division of Sanofi Pasteur Inc., was awarded a single-award Indefinite Delivery Contract by the Defense Logistics Agency Troop Support Medical (a defense agency under the Medical Supply Chain) on February 4, 2026, with an ultimate completion date of February 3, 2027. The contract, valued at $13.13 million, procures Injectable Influenza Vaccine for the 2026-2027 flu season in prefilled syringes. The procurement encompasses approximately 3.08 million doses with a guaranteed minimum of 2.31 million doses (75 percent of annual estimate) and a maximum ceiling of 4.62 million doses (150 percent of annual estimate). The vaccines must be FDA-approved for multiple age categories including individuals 65 years and older, 18 years and older, 3 years and older, and pediatric populations aged 6 months to 35 months, and must be CDC Advisory Committee on Immunization Practices-recommended formulations as determined by the FDA Vaccines and Related Biological Products Advisory Committee. Delivery of all vaccine supplies is required to the Defense Depot in New Cumberland, Pennsylvania, following a staggered schedule: 40 percent by August 14, 2026, 25 percent by August 28, 2026, 25 percent by September 11, 2026, and the remaining 10 percent by September 25, 2026. The contract operates under NAICS code 325414 for Biological Product Manufacturing and PSC code 6505 for Drugs and Biologicals. This procurement represents a critical component of the Department of Defense's influenza immunization program and supports national public health preparedness by ensuring adequate vaccine supply across federal populations. The contract includes no set-aside designations and leverages Sanofi Pasteur's established expertise as a major global supplier of vaccines to federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 2/3/26 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Injectable Influenza Vaccine | SPE2DP25R0005 | Defense Logistics Agency Troop Support Medical | Pre-Solicitation 1/2 | 7/22/25, 2:39 PM | |
Injectable Influenza Vaccine | SPE2DP25R0005 | Defense Logistics Agency Troop Support Medical | Solicitation 2/2 | 8/22/25, 9:04 AM |